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Summary.-After the implantation of ovarian tissue into the spleen of gonadecto-
mized female Sprague-Dawley rats (splenic ovary), luteomata and later benign
granulosa or granulosa-theca cell tumours develop. Treatment of these rats with
7,12 dimethylbenz(a)anthracene (DMBA), given intravenously, 2 mg/kg body weight
weekly,totaldosage40 mg/kg, immediately andespecially25 weeks afterimplantation
of ovarian tissue into the spleen, led to malignant, partially metastasizing granulosa,
and in one case theca cell tumours, 16-46 weeks after beginning the carcinogen
treatment. No malignant neoplastic growth was seen when diethylnitrosamine
(DEN), 20 mg/kg once weekly for life, was injected subcutaneously immediately or
25 weeks after implanting ovarian tissue.
Since the normal, non-implanted rat ovary was not affected by DMBA treatment
the malignant transformation of splenic ovaries in the respective experimental
groups may be related to the increased stimulation by pituitary gonadotrophins and
formation of luteomata or beginning granulosa and theca cell proliferations.
OVARIAN tissue was found to develop
benign granulosa or granulosa-theca cell
tumours after implantation into the
spleen of gonadectomized rats (Biskind
and Biskind, 1944) as the result of an
adaptive hyperplasia (Bungeler and
Dontenwill, 1959). This mechanism has
been explained by uninhibited pituitary
stimulation (Heller and Jungck, 1947;
Miller and Pfeiffer, 1950; Achilles and
Sturgis, 1951; Kullander, 1956); because
steroids secreted from the implant pass
directly through the portal system to the
liver where they are inactivated (Golden
and Sevringhaus, 1938; Leavitt, Carlson
and Meyer, 1971), and the feedback
mechanism is interrupted between pitui-
tary and ovarian tissue.
Since chemnicals may lead to malignant
transformation, the effects of a polycyclic
hydrocarbon and a nitroso-compound
were examined in this model of induction
of benign ovarian tumours (splenic
ovaries).
* Supported by Deutsche Forschungsgemeinschaft.
MATERIALS AND METHODS
One hundred and ten female, 3-month old
Sprague-Dawley rats from our colony were
ovariectomized under ether (Pronarcosi,
Hoechst) anaesthesia, and a piece of ovary
2 mm in diameter was implanted into the
spleen according to the method described by
Biskind and Biskind (1949). The animals
were kept in groups of 3 in Makrolon cages
(Type III) under standard laboratory con-
ditions (room temperature 22 ± 1°C; relative
humidity 55 ± 5%; air exchange 8 x per
hour), and Hope Farms RMH-TMB pelleted
diet and water ad libitum. Immediately
after the ovariectomy and implantation, one
group (20 rats) was given 2 mg of 7,12
dimethylbenz(a)anthracene (DMBA) (special
15% fat emulsion with 7,12 dimethylbenz(a)-
anthracene 5 mg/g; the Upjohn Company,
Kalamazoo, Michigan) per kg body weight,
intravenously once weekly for 20 weeks (a
total dosage of40 mg DMBA/kg). A second
group (20 rats) received 20 mg of diethyl-
nitrosamine (DEN) per kg subcutaneously,
once weekly for life. Two other groups (20
animals each) were treated by the sameINDUCING MALIGNANT OVARIAN TUMOURS IN RATS
FIG. 1.-Granulosa-theca cell tumour (partially luteinized) in the spleen, 71 weeks after implanting
ovarian tissue (control). x 2.
scheme 25 weeks after ovariectomy and
implantation ofovarian tissue into the spleen.
Before treatment these animals were lapara-
tomized in order to examine the size of the
splenic ovaries after this period. Controls
consisted of 3 groups, 10 rats receiving a fat
emulsionintravenously (intravenous fatemul-
sion without dextrose: the Upjohn Company,
Kalamazoo, Michigan) (solvent for DMBA),
10 rats receiving 0-9% saline (solvent for
DEN) subcutaneously and 10 untreated rats.
Dead animals were autopsied and the
organs fixed in 4% buffered formalin; para-
plast sections were stained with haematoxylin
and eosin and van Gieson; the splenic
ovaries were also stained with PAS and
Alcian blue, Gomori, Masson-Goldner and
Sudan III. The surviving control animals
were killed after the last treated animal had
died.
RESULTS
1. Controls
Tumours (splenic ovaries), observed in
the spleen of controls from 25 to 71 weeks
after implantation showed a well-encap-
sulated, yellowish or grey-white pattern
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usually up to 20 mm in diameter (Fig. 1)
and in a few cases up to 30 mm. Histo-
logically, clusters and cords of granulosa
cells with mainly uniform, round to oval
nuclei and non-distinct cytoplasm were
found. Occasionally follicular or pseudo-
follicular structures similar to Call-Exner
bodies were seen. Generally, the clusters
and cords were situated in parts of theca
cells with fibre formation (granulosa-theca
cell tumour) (Fig. 2) and cystic alterations
were often observed. Large luteinized
areas resembled a luteoma. There were
no signs of malignancy in these tumours
and no metastases were found. The
splenic ovarian tumours and other tumours
found in the controls are listed in Table I.
2. DMBA treatment
The time of survival after DMBA
treatment immediately after implantation
of ovarian tissue into the spleen was from
22 to 42 weeks. In 14 animals DMBA did
not influence the development of splenic
ovaries in comparison with the controls;
however, 6 animals showed slightly
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FiG. 2.-Granulosa-theca cell tumour showing granulosa cell clusters, highly luteinized granulosa
cells and theca fibres enclosing single luteinized theca cells. H. and E. x 580.
enlarged splenic ovaries with some grey
areas, haemorrhages and necroses.
Similar and more extensive changes
were found in 13 rats given DMBA
intravenously 25 weeks after implantation,
when the splenic ovaries were from 4 to 8
mm in diameter. These animals died with
partly metastasizing ovarian tumours in
the spleen 16-46 weeks later. The splenic
ovaries of these rats were considerably
altered, in contrast to controls. Grey
areas with haemorrhages and necroses
were prominent (Fig. 3); often the tumours
were 50-60 mm in diameter. Occasionally
TABLE I.-Splenic Ovarian and Other Tumours in Rats After Treatment with DMBA
and DEN
Survival time
after beginning
No. of of treatment
Treatment animals (in weeks)
Controls
DMBA
immediately*
DMBA
25 weeks*
DEN
immediatelyt
DEN
25 weekst
Tumours (splenic ovaries)
No. and percentage
Benign Malignant
Other tuniouirs
(tumour bearing animals)
30 25-7] 30 (100%) 0 (0%) Fibroadenoma of mammary gland (1)
Thymoma (1)
Subcutaneous lipoma (1)
20 22-42 14 (70%) 6 (SOOO) Tumours of Zymbal's gland (17 )
Skin tumours (5)
Mammary tumours (5)
Thymoma (1)
Adenoma of adrenal gland (1)
20 16-46 7 (35%) 13 (65°h) Tumouirs of Zymbal's glanid (18)
Skin tumours (4)
Mammary tumours (4)
Adenoma of adrenal gland (1)
20 20-33 20 (100%) 0 (00') Liver tumours (18)
Papillomata of oesophagus (4)
Tubulary adenomata of kidney (2)
20 24-41 20 (]00%) 0 (0O) Liver tumours (19)
Papillomata of oesophagus (2)
Tuibulary adenomata of kidney (3)
Adenoma of adrenal gland (1)
* 9 mg/kg i.v. weekly for 20 weeks, started immediately or 25 weeks after ovarian implantation.
t 20 mg/kg s.c. per week, continued until death of the animal. Dosage started immediately or 25 weeks after ovarian implantation.
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Animals
with
leukaemias
0
11
13
0
0INDUCING MALIGNANT OVARIAN TUMOURS IN RATS
FIG. 3.-Malignant granulosa cell tumour in the spleen 52 weeks after implanting ovarian tissue and
27 weeks after beginning DMBA treatment. The tumour shows necroses and haemorrhages.
Close to the rest of the spleen an area showing the benign pattern of the granulosa-theca cell
tumour from which the malignant neoplasm developed. x 2 2.
FIG. 4.-Malignant granulosa cell tumours showing invasion of a blood filled (left) or fluid filled
(right) " folliculoma malignum " into the surrounding tissue and into a lymph capillary (left).
H. and E. x 260.
49the animals died from rupture of these
tumours and bleeding into the abdominal
cavity.
Histologically, in both groups these
areas showed malignant granulosa cell
proliferation with polymorphism and
hyperchromasia of the nuclei as well as
numerous mitoses. In addition to solid
tumour parts, typical fluid- or blood-
filled cystic changes occurred similar to
the " folliculoma malignum " (Novak and
Woodruff, 1968), which resembled the
structures of Graafian follicles. Cells of
these " follicles " invaded the surrounding
tissue (Fig. 4) or filled the lumen of the
cysts by papillary growth (Fig. 5), and
central necroses very often occurred. In
3 cases metastases were found in liver and
lungs (Fig. 6 and 7). One tumour, 41
weeks after beginning ofDMBA treatment
and 66 weeks after implantation, showed a
striking solid consistency (Fig. 8) and was
diagnosed as a malignant thecoma with
only a few granulosa cell areas. Spindle-
like and sometimes epithelioid cells formed
an irregular, whorl-like pattern (Fig. 9),
and frequent mitoses and typical forma-
tion of fibres were seen. Areas of calci-
fication could be found. Malignant cells
invaded the vascularised connective tissue.
Luteinization of the malignant granulosa
cell tumours and the thecoma was diffuse
and minimal in comparison with the
controls. When DMBA was administered
immediately after implantation of ovarian
tissue, the first malignant transformation
in the splenic ovary was seen after 22
weeks, and 16 weeks after treatment when
administration began 25 weeks later. In
general, the rats of both DMBA treated
groups did not die from malignant splenic
ovaries but from leukaemias, often bi-
lateral tumours (adenomata and mostly
carcinomata) of the periauricular seba-
ceous gland (Zymbal, 1933); occasionally
multiple skin (sebaceous adenomata, se-
baceous basal and squamous cell carcino-
mata) or mammary tumours (adenocarci-
nomata, fibrosarcomata and in one case a
carcinosarcoma). The results for these
groups can be seen in Table I.
3. DEN treatment
The splenic ovaries of rats treated
immediately or 25 weeks after implanta-
tion showed macroscopically and histo-
logically no differences from the controls.
Most of these animals died from extensive
hepatomata and partly metastasizing
hepatocellular carcinomata. Table I
shows the results of the DEN experi-
mental groups.
DISCUSSION
These experiments show that treat-
ment of splenic ovaries with DMBA led to
the transformation of the ovarian tissue
into malignant, partially metastasizing
tumours, as has been briefly reported
previously (Hilfrich and Mohr, 1971,
1972). Since the neoplasms were granu-
losa and theca cell tumours, ovarian cells
were the tissue of origin.
The histogenesis of tumour develop-
ment after implantation of ovarian tissue
into the spleen of ovariectomized rats has
been described by several authors (Biskind
and Biskind, 1944; 1949; Deane and
Fawcett, 1956; Kullander, 1956; Ranz,
1960; Myhre, 1962). The neoplastic
alterations in the ovarian implant develop
because follicles remain unruptured and
after destruction of the oocytes, corpora
lutea are formed resulting in the develop-
ment ofluteomata. Areas with granulosa
cells showing increased mitotic activity
are seen 4-8 months after implantation.
The tumours are not uniform in their
composition; luteal tissue, areas of granu-
losa cells and parts oftheca cells embedded
in fibrous connective tissue are present in
different patterns. Metastases of these
tumours were not observed (Biskind and
Biskind, 1949; Bungeler and Dontenwill,
1959; Ranz, 1960).
Granulosa or granulosa-theca cell
tumours after implantation of ovarian
tissue into the spleen were also reported in
mice, rabbits and guinea-pigs (Lipschutz,
1946; Furth and Sobel, 1947; Li and
Gardner, 1947; Peckham, Breene and
Jeffries, 1948; Miller and Pfeiffer, 1950;
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FIG. 5.-Area of a malignant granulosa cell tumour showing papillary proliferation in a " folliculoma
malignum ". Masson-Goldner x 580.
FIG. 6.-Malignant granulosa cell tumour with metastases in the liver and lung. The animal was
treated with DMBA 25 weeks after implanting ovarian tissue in the spleen and died 32 weeks
after beginning treatment. Histologically, this tumour showed only densely situated pleomorphic
granulosa cells with numerous mitoses and sometimes a tendency to arrange Call-Exner bodies.
Here, no " folliculoma malignum " was seen. x 0 8.
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FIG. 7. Metastasis of a granulosa cell tumour in the liver. H. and E. x 580.
FIG. 8.-Malignant thecoma showing a sarcomatous cut surface with focal calcification. The animal received DMBA treatment 25 weeks after implanting ovarian tissue into the spleen and died 41 weeks after beginning of treatment. x 1
-5.INDUCING MALIGNANT OVARIAN TUMOURS IN RATS
FIG. 9. Malignant thecoma showing an irregular, whorl-like pattern of spindle shaped or epithelioid
cells and fibre formation (same tumour as Fig. 11). II. and E. x 580.
Klein, 1952; Li and Gardner, 1952;
Iglesias, Mardones and Lipschutz, 1953;
Gardner, 1955; Mardones, Iglesias and
Lipschutz, 1955; Guthrie, 1957). In rats
the application of DMBA led to the
malignant transformation of the ovarian
tissue and to the development ofmalignant
granulosa, and in one case theca cell
tumours. The malignant neoplastic
changes observed in 6 animals (30%o)
treated with DMBA immediately follow-
ing implantation ofovarian tissue into the
spleen were mostly found to be multi-focal
inside the benign luteal changes or in
granulosa-theca cell proliferations. In
comparison with these observations, in the
second DMBA treated group (application
25 weeks after implantation), more exten-
sive malignant tumours were found in a
higher percentage of animals (65%) and
parts of the " normal " benign splenic
ovary were rarely observed. It may
therefore be assumed that the carcinogen
only affects the stage of luteinization or
the proliferation of granulosa and theca
cells. Possibly, the similarity between the
chemical structure ofthe polycyclic hydro-
carbon and steroid hormones (Yang et al.,
1961) and the similarity oftheir biological
effects (Jull, 1956) interfere with the
metabolism of luteinized cells. Since no
malignant alterations were found after
DEN treatment, the mechanism described
before might be supported.
In contrast to the results in mice
(Howell, Marchant and Orr, 1954;
Marchant, 1957; Mody, 1960; Biancifiori,
Bonser and Caschera, 1961; Krarup, 1967,
1970; Kuwahara, 1967; Krarup and Loft,
1971) and hamsters (Toth, 1971) where
DMBA treatment led to the development
of granulosa or granulosa-theca cell
tumours, rat orthotopic ovaries are not
affected by DMBA (Marchant, 1957;
Kuwahara, 1967). Here, malignant trans-
formation was found only in implanted
ovarian tissue stimulated continuously by
pituitary gonadotrophins, and perhaps the
gonadotrophins act as syn- or co-carcino-
genic factors in this model.
The author wishes to thank Professor
Dr Ulrich Mohr for his support throughout
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